30 Posts Not To Miss From ASCO 2026 Day 3

RASolute 302 Trial at ASCO 2026 Plennary Session: Daraxonrasib Improves Survival Versus Chemotherapy in Previously Treated Metastatic PDAC

Yvonne Awards 2026 Honored Leaders Shaping the Future of Oncology

Talha Badar: Key Hematologic Malignancy Posters from ASCO26

HARMONi-6 Trial at ASCO Plenary 2026: Ivonescimab Plus Chemotherapy Improves Overall Survival in Advanced Squamous Non-Small Cell Lung Cancer

PROTEUS Trial at ASCO 2026 Plenary Session: Perioperative Apalutamide Plus ADT in High-Risk Localized or Locally Advanced Prostate Cancer.

LIBRETTO-432 Trial at ASCO 2026 Plenary Session: Adjuvant Selpercatinib in RET Fusion-Positive NSCLC

SARC041 Trail at ASCO 2026 Plenary Session: Abemaciclib in Advanced Dedifferentiated Liposarcoma

https://www.linkedin.com/posts/richi-entrepreneurs_the-11th-edition-of-richi-entrepreneurs-activity-7262183388642525184-dNqh?utm_source=share&utm_medium=member_desktop